Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.

The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Digital ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The adoption of AI agents in healthcare is an essential strategy for institutions that seek efficiency, agility and smarter ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The Joint Commission June 11 announced a new partnership with the Coalition for Health AI to help accelerate the development ...

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

As pharmaceutical and medical device companies race to modernize how they engage doctors and patients, leaders face a central ...

Wandercraft announced that it secured $75 million in funding as part of its Series D financing round to support its robotic ...

The Hill: FDA To Phase Out Some Animal Testing Requirements The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing ... using a range of approaches,” including ...